Tissue-Engineered Construct Based on Amniotic Membrane and Calcium Alginate for Cesarean Section Wound Healing

This clinical trial aims to evaluate the safety and efficacy of an experimental tissue-engineered construct (TEC) based on amniotic membrane and calcium alginate for promoting epithelialization and improving scar quality in patients after cesarean section. The study will assess both biological and clinical indicators of wound healing, including cytokine dynamics (IL-6, IL-10), ultrasound characteristics, and patient-reported outcomes.

NCT Number	NCT07241013
Lead Sponsor	Asfendiyarov Kazakh National Medical University Collaborators: Center for Perinatology and Pediatric Surgery, Almaty, Kazakhstan, Zhalyn Scientific and Technical Production Center, Almaty, Kazakhstan
Conditions	Skin Wound Healing After Cesarean Section, Cesarean Section Scar Healing
Enrollment	100 participants
Start Date	2025-11
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-11-21